Ded by the European Social Fund. Conflicts of Interest: The authors declare no conflict of interest.
Annals of Medicine and Surgery 75 (2022)Contents lists available at ScienceDirectAnnals of Medicine and Surgeryjournal homepage: elsevier/locate/amsuCase ReportPost-COVID-19 vaccine medium-vessel vasculitis and acute anterior uveitis, causation vs temporal relation; case report and literature reviewAbdul-Wahab Al-Allaf a, , Almurtada Razok b, Yousr Al-Allaf c, Loai Aker daDepartment of Rheumatology, Hamad Health-related Corporation, P.O 3050, Doha, Qatar Division of Internal Medicine, Hamad Healthcare Corporation, P.O 3050, Doha, Qatar c Imperial College School of Medicine, London, Uk d Department of Radiology, Hamad Health-related Corporation, P.O 3050, Doha, QatarbA R T I C L E I N F OKeywords: COVID-19 vaccine Vasculitis Celiac trunk Anterior uveitis Immunosuppressive medicationsA B S T R A C TIntroduction: and value: Multiple immunologic phenomena were reported following the administration of COVID-19 vaccines. On the other hand, the important point is the fact that their possible association with medium-vessel vasculitis involving the celiac trunk and its branches with acute anterior uveitis within the very same patient has not been reported before. Case presentation: In this manuscript, we’re reporting a case of a middle-aged gentleman who created vasculitis involving the celiac trunk and its branches, and acute anterior uveitis a single week and 3 weeks just after the second dose of Pfizer BioNTech COVID-19 vaccine, respectively. The patient showed substantial clinical and radiographic improvement soon after getting corticosteroids and azathioprine. Clinical discussion: Previously reported instances of vasculitis following COVID-19 vaccines included both renallimited and more generalized vasculitis with some getting good and other individuals adverse for ANCA (anti-neutrophil cytoplasmic antibodies). Nonetheless, it is actually worth mentioning that most cases responded to immunosuppressive remedy. Post-COVID-19 vaccine uveitis was reported in sufferers with diverse age spans including both anterior and posterior uveitis, with remission becoming achieved immediately after the use of corticosteroids. Conclusions: Multiple situations of vasculitis and acute anterior uveitis had been reported following COVID-19 vaccines; nevertheless, it’s crucial to mention that a lot more study is needed to establish an association among the COVID19 vaccine and both vasculitis and acute anterior uveitis.CD44 Protein supplier In our opinion, the rewards in the COIVID-19 vaccine largely outweigh the anticipated risks.CD150/SLAMF1 Protein web 1.PMID:23912708 Introduction Since the emergence on the COVID-19 virus in late 2019, the world has been preoccupied with its damaging impacts on public overall health worldwide. Because of the catastrophic effects of the COVID-19 pandemic, the Meals and Drug Administration (FDA) approved the use of many vaccines on an emergency basis, which contain Pfizer BioNTech, Moderna and Johnson Johnson [1]. After the widespread use of COVID-19 vaccines, a number of regional and systemic reactions had been observed. The nearby unwanted effects included pain, erythema and swelling [2], but extra worrying had been the numerous systemic reactions which includes many different immune-mediated circumstances including Guillain-Barre syndrome, Vaccine-associated Immune Thrombosis and Thrombocytopenia (VITT)syndrome and myocarditis [3]. A lot of situations of small-vasculitis following the COVID-19 vaccine were reported [4,5]. We report a case of isolated medium-vessel vasculitis involving the celiac trunk and.